Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Hillman Solutions
HLMN
$1.54B
| $618K | ﹤0.01% |
+58,129
| New | +$543K |
|
|
ACOR
2777
DELISTED
Acorda Therapeutics
ACOR
| $618K | ﹤0.01% |
46,761
+1,000
| +2% | +$14.5K |
|
|
CATC
2778
DELISTED
CAMBRIDGE BANCORP
CATC
| $616K | ﹤0.01% |
9,041
-400
| -4% | -$26.5K |
|
|
LUMO
2779
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $615K | ﹤0.01% |
218,014
-3,600
| -2% | -$10.7K |
|
2780
Invesco S&P 500 High Beta ETF
SPHB
$971M
| $614K | ﹤0.01% |
7,000
-1,900
| -21% | -$157K |
|
|
VINC
2781
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $614K | ﹤0.01% |
6,070
-2,731
| -31% | -$173K |
|
2782
Champions Oncology
CSBR
$74.5M
| $611K | ﹤0.01% |
124,691
-100
| -0.1% | -$585 |
|
2783
ClearOne Inc
CLRO
$10.9M
| $609K | ﹤0.01% |
22,204
-20,560
| -48% | -$362K |
|
2784
Five Point Holdings
FPH
$373M
| $609K | ﹤0.01% |
194,700
-22,100
| -10% | -$69.8K |
|
2785
Goldgroup Mining Inc.
GORO
$157M
| $609K | ﹤0.01% |
1,401,090
+100,400
| +8% | +$30.7K |
|
2786
8x8 Inc
EGHT
$269M
| $605K | ﹤0.01% |
224,195
-270,435
| -55% | -$818K |
|
2787
Smith-Midland
SMID
$144M
| $604K | ﹤0.01% |
12,851
-3,949
| -24% | -$161K |
|
2788
First Trust NASDAQ Cybersecurity ETF
CIBR
$14.4B
| $603K | ﹤0.01% |
+10,700
| New | +$601K |
|
|
SNCR
2789
DELISTED
Synchronoss Technologies
SNCR
| $603K | ﹤0.01% |
72,274
+14,700
| +26% | +$116K |
|
2790
Dimensional International Small Cap Value ETF
DISV
$4.95B
| $601K | ﹤0.01% |
22,100
-24,100
| -52% | -$620K |
|
2791
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.62B
| $600K | ﹤0.01% |
+21,442
| New | +$586K |
|
2792
Schwab Fundamental US Small Company Index ETF
FNDA
$9.12B
| $599K | ﹤0.01% |
21,000
+5,000
| +31% | +$136K |
|
2793
OFG Bancorp
OFG
$2.23B
| $596K | ﹤0.01% |
+16,200
| New | +$586K |
|
|
SHCO
2794
DELISTED
Soho House & Co
SHCO
| $596K | ﹤0.01% |
105,200
+49,700
| +90% | +$301K |
|
|
ACCS
2795
ACCESS Newswire
ACCS
$25.6M
| $592K | ﹤0.01% |
45,838
+2,592
| +6% | +$38.2K |
|
2796
Telephone and Data Systems
TDS
$3.82B
| $589K | ﹤0.01% |
36,784
-44,800
| -55% | -$765K |
|
2797
InnovAge Holding
INNV
$1.54B
| $587K | ﹤0.01% |
132,300
+2,500
| +2% | +$13.1K |
|
|
ATXS
2798
DELISTED
Astria Therapeutics
ATXS
| $583K | ﹤0.01% |
41,400
+27,200
| +192% | +$339K |
|
2799
US Foods
USFD
$22.2B
| $583K | ﹤0.01% |
10,800
-129,000
| -92% | -$6.36M |
|
|
TTSH
2800
DELISTED
Tile Shop Holdings
TTSH
| $582K | ﹤0.01% |
82,800
+60,000
| +263% | +$404K |
|
Similar funds
Renaissance Technologies's Q1 2024 Portfolio in Review
As of Q1 2024, Renaissance Technologies held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Chevron worth $331M.
- Renaissance Technologies's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Renaissance Technologies added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Renaissance Technologies's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Renaissance Technologies fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Renaissance Technologies's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Renaissance Technologies opened 563 new positions and closed 582 in Q1 2024.
- Renaissance Technologies's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.